Cagan Gurer

Company: TScan Therapeutics

Job title: VP, Discovery

Seminars:

Expanding Patient Coverage for TCR-T Therapies by Broadening HLA Type Targeting 9:30 am

• Application of TargetScan discovery platform to diverse HLA types for novel target epitope identification • Using ReceptorScan to identify lead TCRs for novel HLA epitopes • Leveraging proprietary human proteome libraries across diverse HLAs to assess potential off-target safety risks for TCRsRead more

day: Day Two